CiLostAzol for pReventIon of Recurrent sTroke in Africa
NCT06919835
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
1100
Enrollment
OTHER
Sponsor class
Conditions
Stroke
Interventions
DRUG:
Cilostazol 100 mg
Sponsor
Northern California Institute of Research and Education